TY - JOUR
T1 - Paracoccidioidomycosis due to P lutzii
T2 - The importance of neutrophil/lymphocyte ratio in the symptomatic and asymptomatic phases in severe cases
AU - Nery, Andreia Ferreira
AU - de Camargo, Zoilo Pires
AU - Rodrigues, Anderson Messias
AU - Portela, Tiago Ferreira
AU - Hoffmann-Santos, Hugo Dias
AU - Dambros, Pedro Vitor Krüger
AU - de Souza, Jânio Felipe Ribeiro
AU - Garcia, Alexandre Carvalho
AU - Santos, Carolina Araújo Damasio
AU - Hagen, Ferry
AU - Hahn, Rosane Christine
N1 - Publisher Copyright:
© 2021 Wiley-VCH GmbH
PY - 2021/8
Y1 - 2021/8
N2 - Background: PCM is a neglected systemic mycosis endemic in Brazil. The middle-west region of Brazil has shown the highest number of PCM by Paracoccidioides lutzii (P lutzii) cases. Differentiating cases of severe PCM from non-severe ones should be a concern at the bedside. Diagnosis of severe PCM by P lutzii is based on the subjectivity of clinical manifestations, which can result in a delay in starting its treatment and, consequently evolution to severe sequelae. There is not laboratory biomarker available to support the early diagnosis of severe PCM that is feasible for all the realities that coexist in Brazil. Objectives: The aim of this study was to investigate the usefulness of laboratory biomarkers as erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) and neutrophil/lymphocyte ratio (NLR) in the diagnosis of severe PCM. Patients/Methods: ESR, CRP and NLR were analysed for 44 patients with PCM by P lutzii and a Receiver Operation Characteristic (ROC) curve were generated to identify the NLR cut-off point and point out the presence of severe PCM. Results: Sixteen (36.4%) had severe PCM and 28 (63.6%) had non-severe PCM. The mean NLR was higher and statistically significant among patients with severe PCM than among those with non-severe PCM. The area under the ROC curve was 0.859 for the diagnosis of severe PCM. The cut-off point for NLR for the diagnosis of severe PCM was 3.318 (sensitivity of 100%, specificity of 77%). Conclusions: According to results, it is plausible to conclude that NLR represents a potential biomarker for the diagnosis of severe PCM.
AB - Background: PCM is a neglected systemic mycosis endemic in Brazil. The middle-west region of Brazil has shown the highest number of PCM by Paracoccidioides lutzii (P lutzii) cases. Differentiating cases of severe PCM from non-severe ones should be a concern at the bedside. Diagnosis of severe PCM by P lutzii is based on the subjectivity of clinical manifestations, which can result in a delay in starting its treatment and, consequently evolution to severe sequelae. There is not laboratory biomarker available to support the early diagnosis of severe PCM that is feasible for all the realities that coexist in Brazil. Objectives: The aim of this study was to investigate the usefulness of laboratory biomarkers as erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) and neutrophil/lymphocyte ratio (NLR) in the diagnosis of severe PCM. Patients/Methods: ESR, CRP and NLR were analysed for 44 patients with PCM by P lutzii and a Receiver Operation Characteristic (ROC) curve were generated to identify the NLR cut-off point and point out the presence of severe PCM. Results: Sixteen (36.4%) had severe PCM and 28 (63.6%) had non-severe PCM. The mean NLR was higher and statistically significant among patients with severe PCM than among those with non-severe PCM. The area under the ROC curve was 0.859 for the diagnosis of severe PCM. The cut-off point for NLR for the diagnosis of severe PCM was 3.318 (sensitivity of 100%, specificity of 77%). Conclusions: According to results, it is plausible to conclude that NLR represents a potential biomarker for the diagnosis of severe PCM.
KW - biomarker
KW - diagnosis
KW - erythrocyte sedimentation rate
KW - neutrophil -lymphocyte ratio
KW - P lutzii
KW - Paracoccidioidomycosis
KW - PCM severity criteria
KW - receiver operating characteristic curve
UR - https://www.scopus.com/pages/publications/85106675796
U2 - 10.1111/myc.13282
DO - 10.1111/myc.13282
M3 - Article
C2 - 33829534
AN - SCOPUS:85106675796
SN - 0933-7407
VL - 64
SP - 874
EP - 881
JO - Mycoses
JF - Mycoses
IS - 8
ER -